Re (RMAX) EBITDA (2012 - 2026)

Re (RMAX) has 15 years of EBITDA data on file, last reported at -$7.8 million in Q1 2026.

• On a quarterly basis, EBITDA fell 245.78% year-over-year to -$7.8 million in Q1 2026; TTM through Mar 2026 was $33.9 million, a 17.48% decrease from a year earlier, with the FY2025 full-year figure at $47.0 million, up 17.08% from the prior year.
• EBITDA for Q1 2026 stood at -$7.8 million, down from $9.3 million in the prior quarter.
• Over the last five years, EBITDA for RMAX reached as high as $18.3 million in Q3 2025 and fell as low as -$21.0 million in Q3 2023.
• Historically, EBITDA has averaged $6.3 million across 5 years, with a median of $7.6 million in 2022.
• Across the five-year window, EBITDA slumped 501.11% in 2023 and jumped 172.44% in 2024, its largest moves.
• Year by year, EBITDA stood at $8.5 million in 2022, then sank by 214.58% to -$9.7 million in 2023, then jumped by 144.03% to $4.3 million in 2024, then jumped by 118.17% to $9.3 million in 2025, then tumbled by 183.97% to -$7.8 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were -$7.8 million in Q1 2026, $9.3 million in Q4 2025, and $18.3 million in Q3 2025.